Chemoinformaics analysis of alpha-Eudesmol acetate
| Molecular Weight | 280.408 | nRot | 2 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 12 |
| Exact Molecular Weight | 280.204 | nRing | 2 |
| Solubility: LogS | -3.076 | nHRing | 0 |
| Solubility: LogP | 3.733 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 49.4662 |
| nHD | 1 | BPOL | 30.6938 |
| QED | 0.622 |
| Synth | 4.218 |
| Natural Product Likeliness | 2.854 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.206 |
| Pgp-sub | 0.003 |
| HIA | 0.008 |
| CACO-2 | -4.513 |
| MDCK | 0.000023 |
| BBB | 0.408 |
| PPB | 0.916936 |
| VDSS | 1.301 |
| FU | 0.0913481 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.77 |
| CYP2c9-inh | 0.093 |
| CYP2c9-sub | 0.196 |
| CYP2d6-inh | 0.064 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.152 |
| CYP3a4-sub | 0.258 |
| CL | 5.111 |
| T12 | 0.293 |
| hERG | 0.02 |
| Ames | 0.008 |
| ROA | 0.3 |
| SkinSen | 0.355 |
| Carcinogencity | 0.109 |
| EI | 0.821 |
| Respiratory | 0.604 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.651534 |